咨詢熱線
15000266580
15000266580
簡要描述：TIB-196 U266B1 人外周淋巴細胞，ATCC 細胞|細胞系|細胞株|腫瘤細胞|細胞|貼壁細胞|懸浮細胞|;細胞庫管理規(guī)范，提供的細胞株背景清楚，提供參考文獻和培養(yǎng)條件！
產品型號：TIB-196廠商性質：生產廠家 更新時間：2024-08-29訪 問 量：1682 產品分類
Product Category相關文章
Related Articles詳細介紹
TIB-196 U266B1 人外周淋巴細胞
| ATCC® Number: | TIB-196™ | Price: | $269.00 |
| Designations:U266B1 [U266]Depositors: NK NilssonIsotype:IgE; lambda light chainBiosafety Level:1Shipped:frozenMedium & Serum:See PropagationGrowth Properties:suspensionOrganism:Homo sapiens (human)Morphology:lymphoblast Source:Organ: peripheral blood Disease: myeloma; plasmacytoma Cell Type: B lymphocyte;Cellular Products:immunoglobulin; monoclonal antibody; interleukin 6 (interleukin-6, IL-6)Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.TIB-196 U266B1 人外周淋巴細胞Applications:transfection host (Nucleofection technology from Lonza)DNA Profile (STR):Amelogenin: X,Y CSF1PO: 12,13 D13S317: 12 D16S539: 10 D5S818: 11,12 D7S820: 11,12 THO1: 5,7 TPOX: 8 vWA: 17Age:53 years adultGender:maleComments:U266 cells have been reported to produce human IL-6.Propagation:ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 15%.Subculturing:Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 3 x 10 exp5 cells/ml and maintain between 1 x 10 exp5 and 1 x 10 exp6 cells/ml.Preservation:culture medium 95%; DMSO, 5%Related Products:Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001recommended serum:ATCC 30-2020References:1180: Nilsson K, et al. Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clin. Exp. Immunol. 7: 477-489, 1970. PubMed: 409774522377: Kawano M, et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332: 83-85, 1988. PubMed:325806032396: Kolanus W, et al. alphaLbeta2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-1 a cytoplasmic regulatory molecule. Cell 86: 233-242, 1996. PubMed: 8706128 TIB-196 | |||
產品咨詢
掃一掃 微信咨詢
